A Study to Compare How Well Gadoquatrane Works and Its Safety With an Already Available Contrast Agent for MRI in People With Any Known or Suspected Problems of the Body (Except Brain or Spinal Cord-related Problems)

Clinical trial NCT05915728 · COMPLETED

Trial details

NCT number: NCT05915728
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Contrast Enhancement in Magnetic Resonance Imaging Non-central Nervous System Pathology

Start date: 2023-07-24
Primary completion: 2024-05-31
Enrollment: 404

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.